LANOXIN
NDC 59212-242, digoxin, tablet, from Advanz Pharma (US) Corp..
- Product NDC
- 59212-242
- Status
- Listed
- Labeler
- Advanz Pharma (US) Corp.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020405
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59212-242 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIGOXIN.125 mg/1
Pharmacologic classes
Cardiac Glycoside [EPC]; Cardiac Glycosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59212-242-55 | 59212024255 | 100 TABLET in 1 BOTTLE (59212-242-55) |
| 59212-242-56 | 59212024256 | 10 BLISTER PACK in 1 CARTON (59212-242-56) / 10 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d91e3646-4c63-4512-ab22-db39c085c4dc
Use it
Look up 59212-242 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59212-242 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59212-242. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.